We monitor your progress and adjust as needed
Staying hydrated is crucial, especially as dehydration can exacerbate side effects including headaches
The popularity of GLP-1s continues to grow, and so do the number of conditions they're approved to treat
Sensitive spectrophotometric assay for plasma oxalate
19,84 Hepatocyte-specific SIRT1 knockout mice display liver steatosis, triglyceride accumulation, and increased de novo lipogenesis, even under standard dietary conditions, accompanied by SREBP-1c activation and impaired PGC-1/peroxisome proliferator-activated receptor alpha (PPAR) signaling
Typical weight loss timeline based on clinical trials: Months 12 (dose escalation phase): Weight loss is typically modest during this period as patients are on sub-therapeutic doses